Research on malaria and the fight against it. Covers red-blood-cell inflammation, malaria resurgence, drug-resistant parasites, and mosquito-based control.
Scientists have identified key genes and gene regulation mechanisms in malaria parasites, which could lead to the development of new vaccines. The study's findings may help researchers understand when different genes switch on and off as the parasite metamorphoses through its complex life cycle.
Researchers identified a subset of proteins vital to malaria parasite's survival in host red blood cells and a unique mechanism for protein export. This discovery allows for focus on key proteins for developing antimalarial drugs.
Scientists at Northwestern University have identified a signal on exported parasite proteins that enables the malaria parasite to target red blood cells. This discovery provides a new understanding of the complex mechanisms underlying malaria infection and offers promising leads for developing new treatments.
Researchers found that HIV-1 protease inhibitors, such as saquinavir and ritonavir, effectively inhibit P. falciparum growth and demonstrate anti-malarial activity. The study builds on previous findings of antiretroviral agents reducing parasite adhesion to endothelial surfaces.
Researchers have discovered VAR2CSA, a protein that enables malaria parasites to infect the placenta during pregnancy. Women with high levels of antibodies against this protein experience fewer complications and give birth to healthier babies.
Researchers develop mathematical model to predict mosquito-borne infection risk, finding that peak biting rates occur near breeding sites and highest human density. The proportion of infectious mosquitoes peaks where older populations are found, leading to surprising predictions about risk hotspots.
A new malaria vaccine trial found only 10% vaccine efficacy in Gambian adults, but the DNA/MVA vaccine group showed a significantly stronger immune response than the rabies vaccine group. The researchers are planning further trials to address this issue and develop a more effective malaria vaccine.
Researchers found that none of the 35 children with moderate-to-severe malaria in Gabon were severely dehydrated. This challenges the long-held view that dehydration is a major contributor to fatal cases of malaria.
A malaria vaccine trial has shown encouraging phase II results, demonstrating a 30% reduction in clinical episodes of malaria among young children. The RTS,S/AS02A vaccine has also shown effectiveness in preventing subsequent new infections and severe malaria cases.
A new report highlights the potential of biotechnologies in improving health in developing countries. The report proposes a global institute to share and promote the benefits of genomic sciences, aiming to save tens of millions of lives per year.
A study by the Centers for Disease Control and Prevention (CDC) found that most US malaria deaths are preventable, with human error and inadequate medical care contributing to nearly two-thirds of cases. The CDC has expanded resources available to provide critical information on prevention and treatment of malaria.
A study of US travelers who died from malaria between 1963 and 2001 found that most deaths were preventable with proper medication and medical care. The researchers call for better education and resources for travelers and healthcare providers to reduce malaria-related deaths.
A recent study has identified previously unknown mutations in the pfrct gene as key players in Plasmodium falciparum's resistance to halofantrine and amantadine. These mutations may also restore sensitivity to chloroquine, a widely used antimalarial drug. The findings suggest a new approach to combating chloroquine-resistant malaria.
Researchers at Johns Hopkins University have designed dual-action drugs based on an ancient folk remedy, which shows promising results in fighting malaria and prostate cancer. The new compounds outperform current treatments in rodent models, with some being more effective and safer than existing medications.
Scientists warn of international spread of antimalarial drug resistance, tracing mutations to South East Asia and recommending screening of passengers from affected regions. Artemisinin-based combination therapy may help slow the spread, but a coordinated global response is needed.
A new study found that undernutrition significantly contributes to the global malaria burden, particularly in children less than 5 years old. Well-nourished children are better equipped to fight and survive malaria infection.
A study of 326 children with severe malaria found that 61% had retinopathy, which was associated with higher death rates and prolonged coma. The researchers suggest that retinal signs may be related to cerebral pathophysiology in childhood CM.
A laboratory-based study suggests that inadequate vaccines could lead to the emergence of more virulent malaria strains, potentially making them more dangerous to non-immunized populations. The research found that immunity accelerates the evolution of virulence in malaria parasites, even after mosquito transmission.
A new study reveals that improved nutrition can prevent over half of the world's child deaths every year. Researchers found that even mild undernutrition increases a child's risk of dying from diarrhea, pneumonia, malaria, and measles by two-fold. Investing in child nutrition interventions could save millions of young lives.
The partnership aims to enhance Peruvian research capacity in biomedical research, including lab-based and fieldwork. The project will cover research ethics, health economics, and train local researchers, physicians, biologists, nurses, and students.
Researchers identified a plant-like enzyme, CDPK4, essential for malaria parasite transmission to mosquitoes. The findings provide a promising new target for developing safe and effective anti-malarial drugs.
A study found that rectal artesunate significantly reduced parasite concentrations by over one-third in both children and adults. Early administration of this treatment may help reduce malaria-related morbidity and mortality, particularly in rural communities with limited healthcare access.
A randomized double-blind cross-over study involving 22 healthy volunteers found that Malarone(TM) had no significant effect on vigilance, alertness, or quality of sleep. The results support previous studies showing Malarone(TM) has no impact under normal pressure conditions.
Researchers have identified a new protein target for a universal childhood malaria vaccine, which causes infected red blood cells to stick inside blood vessels. This protein is expressed on the surface of red blood cells during severe childhood malaria but not during adult infections, making it an ideal candidate for vaccination.
Researchers at UC Davis suggest using transposons to introduce genes that block malaria in mosquitoes, which could spread through the population via natural selection and eventually eliminate malaria transmission.
Researchers have discovered two mosquito proteins, TEP1 and LRIM1, that kill the malaria parasite. Eliminating these proteins could block the parasite-mosquito cycle, potentially decreasing malaria prevalence.
The new assay uses fluorochrome binding to detect malaria parasites in cell culture, providing a safer and more cost-effective alternative to current methods. This breakthrough has the potential to drastically reduce the price tag for drug discovery and promote research into tropical parasitic diseases.
The Lancet article reveals that inadequate funding for effective treatments like ACT is contributing to the increase in global childhood malaria deaths. Inappropriate drug distribution by WHO and GFATM is being criticized for wasting international aid money and potentially killing patients.
A meta-analysis of 16 randomised trials shows that artesunate is highly effective in treating malaria when added to other antimalarial drugs. The new combination dihydroartemisinin-piperaquine is also found to be highly efficacious in Vietnam, where multidrug-resistant parasites are common.
A study published in AIDS found that placental malaria significantly increases the risk of mother-to-child HIV transmission. The study, which followed 746 HIV-positive mothers and their infants in Rakai, Uganda, suggests that preventing and treating malaria during pregnancy could reduce transmission rates.
Researchers identified a key process in malaria infection involving G proteins in red blood cells, which can be blocked with beta-blockers to prevent parasite entry. By targeting this process, new approaches for treating malaria may be developed using existing drugs.
A recent study published in PLOS Biology tracked the genomic activity of Plasmodium falciparum in human red blood cells, revealing a surprisingly simple pattern of gene expression. This finding could lead to the identification of the biological function of unknown genes and provide new insights into the life cycle of malaria parasites.
A recent study reveals that an unusually high percentage of genes are expressed during the critical stage of the malaria parasite's life cycle, when it invades red blood cells. The analysis shows a unique pattern of gene expression, with most genes expressed only once in a specific order, suggesting a molecular 'just in time' factory.
The WHO 2003-2008 programme focuses on controlling HIV/AIDS, with a goal of 3 million people in developing countries receiving antiretroviral treatment by 2005. The initiative also aims to strengthen health systems and secure political backing for investment.
Kenyans rely on mosquito nets to keep mosquitoes at bay, but don't view them as a means of preventing malaria. Insecticide-treated bednets can reduce fatal cases by 20%, but effectiveness depends on consistent use and re-impregnation with insecticide.
A recent study published in Malaria Journal found that current funding for the Roll Back Malaria movement is less than 7% of what is needed to achieve its goals. The authors recommend increasing aid and implementing more transparent reporting by donors to ensure the project's success.
Two new studies highlight the severity of sepsis in young US children, with infants and low-birth-weight babies at highest risk. In contrast, imported malaria cases in European countries pose a growing health threat, while disruptions to ICU patients' sleep patterns remain poorly understood.
The study found that despite huge habitat losses, up to 90% of original crustacean diversity may still survive in the few remaining seasonal wetlands in Illinois. The researchers sampled 33 crustacean species from 13 ponds and estimated there could have been as many as 85 species originally.
A new antibiotic, fosmidomycin, has been shown to be effective against the Plasmodium falciparum parasite, with rapid parasite elimination and fever reduction. Cure rates after two weeks were 89%, 88%, and 60% for treatment durations of 5, 4, and 3 days, respectively.
A recent study found a mean warming trend of 0.15 degrees Celsius per decade in East Africa from 1970 to 1998, challenging previous research on malaria's relationship with climate change. The analysis highlights the need for better local monitoring and collaboration between researchers from different fields to assess health implication...
Researchers have gained a new understanding of how quinoline-based drugs work against the Malaria parasite, slowing crystal growth to toxic levels and killing the parasite. The study provides insights into physical chemistry and crystalline surface structure to explain drug action, offering potential solutions to drug resistance.
A genetic variant in the NOS2 gene boosts nitric oxide levels, protecting against malaria disease. This trait explains why some people with malaria have mild symptoms and recover fully.
Research in Kenya found that pregnant women with both HIV and malaria are at higher risk of developing anaemia, while their children also face a greater risk. However, the transmission of HIV from mother to child is less frequent when the mother has a mild malaria infection.
International collaboration sequences mosquito genome, revealing gene functions and immune system adaptations that help understand why only a few species transmit human malaria. The findings provide a head start for researchers to develop new therapies against the disease.
Researchers analyzed Anopheles gambiae genome for transposable elements to develop new ways to prevent malaria transmission. The study's findings have the potential to inform the design of new strategies against this devastating disease.
Researchers at TSRI identified over 2,400 proteins in Plasmodium falciparum, the most deadly malaria parasite, which may lead to new vaccine targets. The study sheds light on how the pathogen causes malaria and could help scientists understand its lifecycle.
The sequencing of both P. falciparum and its insect vector heralds a new era in the fight against malaria. This detailed map of the parasite's 5,300 genes will enable investigators to design targeted anti-malarial drugs.
Researchers at Scripps Research have created a novel technology to detect single nucleotide polymorphisms (SNPs) in malaria parasites, enabling the identification of drug-resistant strains and mapping their spread. The new approach uses gene chips to analyze thousands of SNPs simultaneously.
The malaria parasite evolved from a plant-like organism that survived by photosynthesis, and its relict chloroplast contains genes associated with anti-malarial drug targets. At least 12 new drug targets have been identified, providing leads for safe herbicides and antibiotics.
Researchers have identified a specific gene mutation that confers chloroquine resistance in Plasmodium falciparum malaria parasites, allowing scientists to develop targeted treatments, and also increasing susceptibility to artemisinin and quinine.
The newly-sequenced Anopheles gambiae genome holds promise for developing new insecticides, transmission-blocking vaccines, and mosquito repellants. Researchers identified genes involved in the mosquito's ability to host the malaria parasite and located targets for new insecticides.
A team of researchers from Vanderbilt University identified 276 genes in the Anopheles gambiae genome that code for G-protein-coupled receptors essential to the mosquito's senses. The study found 79 genes involved in its sense of smell and 72 in its taste, shedding light on the insect's strong preference for human hosts.
A new web-based database provides researchers with access to the Plasmodium genome, enabling them to examine chromosome organization, scan for genes and predict protein structures. The database aims to speed up research and discovery in malaria combat, leveraging global collaboration among diverse scientists.
Researchers have found genes in Anopheles mosquitoes that enable them to resist infection by the deadly malaria parasite. The discovery could lead to new strategies to prevent malaria transmission by spreading the parasite-blocking genes among mosquito populations.
The study identifies five insulin-like peptides that regulate mosquito life cycle and disease transmission, providing new targets for genetic interference. The discovery could lead to the development of more effective control methods against malaria.
The Institute for Genomic Research has published a paper analyzing the genome of Plasmodium falciparum, a malaria parasite. The analysis identified about 200 genes producing proteins involved in immune evasion and revealed metabolic pathways, including enzymes that could be targeted by chemotherapy.
Researchers have discovered transposable elements in the malaria mosquito genome, which can be used to introduce new genes to block disease transmission. These elements can also serve as markers to distinguish between populations of mosquitoes with varying resistance levels.
Vitex's INACTINE technology demonstrated complete parasite eradication of Trypanasoma cruzi, Plasmodium falciparum, and Babesia microti parasites. The company's pathogen reduction system meets critical requirements for commercial success, with potential to improve safety of red blood cell transfusions.
Researchers have identified a toxin, glycosylphosphatidylinositol (GPI), that contributes to malaria's virulence and is now being explored for use in a vaccine. The anti-GPI vaccine has shown promise in mice, eliciting an antibody response and reducing immune reactions to the malaria parasite.
A new vaccine targets the parasite's deadly toxin, potentially providing longer-lasting protection against malaria. The vaccine has shown promise in animal trials, with mice surviving after being infected with the parasite when vaccinated against the toxin.